Navigation Links
Paul Meade Accepts Invitation to Speak at AACE Annual Meeting
Date:3/31/2011

ought Leader Select

Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as "thought leaders" and "key opinion leaders") within a host of therapeutic areas such as diabetes, oncology, and neurology.

Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Paul Meade

http://www.profnetconnect.com/Paul_Meade


'/>"/>
SOURCE Thought Leader Select
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
2. NYSE Amex Accepts China Shenghuos Compliance Plan for Continued Listing
3. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
4. The SCOOTER Store Accepts Medicare Contracts
5. FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review
6. FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
7. FDA Accepts Sanofi Pasteurs Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
8. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
9. FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
10. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
11. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... will participate in the upcoming 27 th Annual ... Dana Point, CA.  Dr. Michael ... Oramed, will present a corporate overview on March 10, ...
(Date:3/4/2015)... Mallinckrodt plc (NYSE: MNK ), a ... Global Healthcare Conference at the Loews Miami Hotel in ... 11, 2015. Mark Trudeau, President and Chief Executive Officer of ... to begin at 10:45 a.m. Eastern. Individuals ... webcast information on Mallinckrodt,s Investor Relations website ...
(Date:3/4/2015)... NEWARK, N.J. , March 4, 2015 /PRNewswire/ ... biopharmaceutical company developing innovative medicines for serious women,s ... 1 clinical program demonstrating that its lead product ... had predictable pharmacokinetics (PK), and that contraceptive efficacy ... by SYM-1219 administration. These results will ...
Breaking Medicine Technology:Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Mallinckrodt to Present at Barclays Conference March 11 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 3Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 4Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 5
... MedShape Solutions, Inc., the industry leader in innovative ... developed new, larger sizes of its ExoShape CL, ... simplifies and improves soft tissue graft fixation during ... comes after MedShape received the U.S. Food and ...
... Neuralstem, Inc. (NYSE Amex: CUR ) announced that ... the ongoing Phase Ia trial to test the safety of ... testing the drug in healthy volunteers for safety and tolerability. ... that stimulates new neuron growth in the hippocampus, an area ...
Cached Medicine Technology:MedShape Solutions, Inc. Announces Extension of ExoShape™ Product Line in Response to Surgeon Demand 2Neuralstem Updates NSI-189 Major Depression Trial 2Neuralstem Updates NSI-189 Major Depression Trial 3
(Date:3/4/2015)... March 04, 2015 SIGVARIS ... technology and their first compression therapy collection designed exclusively ... this collection, SIGVARIS USA is proud to announce the ... product line. , Constructed from a unique, extremely fine ... in mind. These socks and thigh-highs offer a tailored ...
(Date:3/4/2015)... According to a new report published ... the U.S. suffer from gastroesophageal reflux disease (GERD), more ... to control acid production, but these can have side ... the problem and lead to other uncomfortable digestive conditions. ... the lower esophageal sphincter does not function properly. Anti-reflux ...
(Date:3/4/2015)... Richey, FL (PRWEB) March 04, 2015 In ... Detox cut the ribbon on their new facility in New ... Chamber of Commerce. The new facility will allow the Florida ... helping end the prescription drug abuse epidemic through treatment and ... reality of drug addiction in the United States, we made ...
(Date:3/4/2015)... 2015 Jeannie Mai, TV personality, fashion maven, ... the cover of the print publication. Mai embraces the overall ... when shopping for clothes and personal care products. In an ... her commitment to an organic diet. She mentions, “Having an ... in gymnastics, but also now as I’m a full time ...
(Date:3/4/2015)... Hoersholm, DK (PRWEB) March 04, 2015 ... of Dako , has joined the Visiopharm ... joins Visiopharm at a time when we are positioned ... quantitative digital pathology for cancer diagnostics and research. ... invested significantly in the development and validation of ONCOtopix™ ...
Breaking Medicine News(10 mins):Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3
... it is observed that women are more likely to experience ... research shows that women are less likely to get prompt ... issue, for 'clotbusting' drugs must be given very rapidly if ... now suggest why there could be a delay in diagnosing ...
... at National Jewish Medical and Research Center report in ... atopic dermatitis, also known as eczema, are susceptible to ... produce effective amounts of two antimicrobial peptides. The findings ... and suggest that a medication containing or inducing the ...
... from a study of a new drug for children ... intravenously every three weeks, was found to be partially ... one of a group of drugs called chloroethylnitrosoureas. They ... shown to help shrink solid tumors, including cancerous brain ...
... showing that calcium channel blockers are more effective at ... group of 1,800 patients were assigned to either lacidipine,// ... are used to treat high blood pressure, but act ... at which calcium flows into cells and so interferes ...
... it is observed that a surgically implanted shunt could help ... draining cerebrospinal fluid. This type of shunting was first used ... used// when there seemed to be a high incidence of ... type of shunting on patients with abnormal amounts of spinal ...
... of the antioxidant vitamin E may assist in reducing ... Health Study and the Health Professionals Follow-Up Study', presented by ... Parkinson's disease. The participants have been followed up for several ... ,Those with a high intake of vitamin E ...
Cached Medicine News:Health News:Eczema patients lack natural antibiotic in skin 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: